Rep. Nancy Pelosi Buys Tempus AI, Inc. (NASDAQ:TEM) Stock

Rep. Nancy Pelosi Buys Tempus AI, Inc. (NASDAQ:TEM) Stock

Representative Nancy Pelosi (Democratic) disclosed the purchase of between $50,001 and $100,000 in shares of Tempus AI, Inc. (NASDAQ:TEM) in a filing made on January 26th, 2026. The transaction, dated January 16th, 2026, was reported as Spouse-owned and listed the asset as "TEMPUS AI INC."

Nancy Pelosi's Recent Trades

• 10/22/2025: Sold $100,001 - $250,000 of AAPL stock
• 6/20/2025: Sold $15,001 - $50,000 of MATW stock
• 6/20/2025: Bought $1,000,001 - $5,000,000 of AVGO stock
• 1/14/2025: Bought $50,001 - $100,000 of TEM stock
• 1/14/2025: Bought $500,001 - $1,000,000 of VST stock
• 1/14/2025: Bought $250,001 - $500,000 of AMZN stock
• 1/14/2025: Bought $250,001 - $500,000 of GOOGL stock
• 1/14/2025: Bought $250,001 - $500,000 of NVDA stock
• 12/31/2024: Sold $10,000,001 - $25,000,000 of AAPL stock
• 12/31/2024: Sold $1,000,001 - $5,000,000 of NVDA stock

TEM Stock Performance

Shares of TEM opened at $61.70 on Monday, down 2.65%. The 50-day moving average is $63.36 and the 200-day moving average is $70.14. The 52-week low is $36.22 and the 52-week high is $104.32.

Since the transaction date (January 16th, 2026), TEM shares have fallen 16.01%, opening at $69.50 on the transaction date. The stock fell 6.01% in the first week and 13.93% over two weeks, and 25.25% over one month.

Tempus AI, Inc. reported a debt-to-equity ratio of 2.63, a current ratio of 3.28 and a quick ratio of 3.12. Market capitalization was $10.09 billion and the TTM price-to-earnings ratio was -50.09 with a beta of 5.23. Latest reported annual revenue was $693.40 million with net income of -$705.81 million; return on equity was -67.96% and net margin was -18.45%, with year-over-year revenue growth of 30.39%.

Key Stories Impacting TEM

• (Positive) Tempus reported preliminary, unaudited Q4 and full-year 2025 results showing approximately 83% revenue growth to about $1.27 billion and a record total contract value topping $1.1 billion. (Jan 11-12, 2026)
• (Positive) Tempus announced a multi-year strategic collaboration with NYU Langone Health to integrate Tempus's multimodal data platform with NYU's Center for Molecular Oncology. (Jan 12-13, 2026)
• (Positive) Tempus launched "Paige Predict," an AI-powered biomarker-prediction solution for digital pathology built on its Paige acquisition. (mid–late Jan 2026)
• (Positive) Tempus struck a multi-year collaboration with AstraZeneca and Pathos to build a multimodal oncology foundation model, a deal reported to include roughly $200 million in data-licensing and model development fees. (announced Apr 23, 2025)
• (Positive) Tempus rolled out a consumer-focused AI personal health app, "Olivia," and the stock experienced notable intraday moves around the announcement in mid-January. (mid Jan 2026)
• (Neutral) Tempus completed a convertible notes offering reported at about $750 million in mid-2025 to fund growth and AI/compute investments. (announced Aug 2025)
• (Positive) Tempus has expanded by acquisition, including Ambry Genetics and Paige in 2025, to broaden hereditary testing and digital pathology capabilities. (2025; integration into 2026)

Analyst Ratings for TEM

Canaccord Genuity reiterated a 'Buy' rating. JP Morgan reiterated a 'Neutral' rating. Morgan Stanley reiterated an 'Overweight' rating. BTIG reiterated a 'Buy' rating. Piper Sandler reiterated a 'Neutral' rating.

Presently, 27 analysts have rated TEM with a buy recommendation, 13 have issued a hold, and 0 have given a sell rating. The average rating is 'Moderate Buy' with an average price target of $89.88.

Institutional Investors Weigh In On TEM

VANGUARD GROUP INC holds 10,258,621 shares valued at $598.80 million. BAILLIE GIFFORD & CO holds 8,741,442 shares valued at $510.24 million. ARK INVESTMENT MANAGEMENT LLC holds 7,557,583 shares valued at $441.14 million. BLACKROCK, INC. holds 7,516,110 shares valued at $438.72 million. CATALYTIC WEALTH RIA, LLC holds 6,761,507 shares valued at $394.67 million. Currently, 57.62% of the stock is owned by institutional investors.

About Nancy Pelosi

Representative Nancy Pelosi is a Democratic member of the U.S. House representing California's 11th congressional district. She has served in the House since 1987 and currently holds the leadership role of Speaker of the House. Pelosi was born in 1940 and is 86 years old.

About TEM

Tempus AI, Inc. is a Medical - Healthcare Information Services company that provides next-generation sequencing diagnostics, PCR profiling, molecular genotyping and other pathology testing. Headquartered in Chicago, Illinois, the company was incorporated in 2015, changed its name from Tempus Labs, Inc. to Tempus AI, Inc. in January 2023, and offers data and analytics products including Insights, Trials, Next/Algos, Hub and Lens.